Le Lézard
Classified in: Health
Subjects: NPT, NAT

BLUE CROSS BLUE SHIELD OF MASSACHUSETTS EXPEDITES ACCESS TO CARE FOR CALIFORNIA MEMBERS AFFECTED BY SEVERE WINTER STORMS


BOSTON, Jan. 6, 2023 /PRNewswire/ -- In response to severe winter storms in California, Blue Cross Blue Shield of Massachusetts (Blue Cross) is expediting access to care for members who may be affected.  

Blue Cross has more than 65,500 members in California. The company is working to ensure those members can access health services and medications quickly and in locations convenient to them. 

Effective immediately and for the duration of the emergency declaration, Blue Cross is allowing:

(Note: Only members with Blue Cross' telehealth benefit will be able to access Well Connection and only via My Blue)

About Blue Cross Blue Shield of Massachusetts
Blue Cross Blue Shield of Massachusetts (bluecrossma.org) is a community-focused, tax-paying, not-for-profit health plan headquartered in Boston. We are committed to the relentless pursuit of quality, equitable and affordable health care with an unparalleled consumer experience. Consistent with our promise to always put our members first, we are rated among the nation's best health plans for member satisfaction and quality. Connect with us on FacebookTwitterYouTube, and LinkedIn.

SOURCE Blue Cross Blue Shield of Massachusetts


These press releases may also interest you

at 21:18
Avirmax CMC Inc. (ACI), a cGMP-licensed CDMO, is announcing the implementation of its newly-developed Sf rhabdovirus-free cell lines (under the generic trademark of Sf-RVFtm) developed for producing recombinant adeno-associated viral vectors (rAAV)....

at 20:35
Biogen Inc.  announced today the outcome of the U.S. Food and Drug Administration's (FDA) Peripheral and Central Nervous System Drugs Advisory Committee meeting on tofersen, an investigational product for the treatment of superoxide dismutase 1...

at 20:30
The "Global Gene Editing Partnering Terms and Agreements 2010 to 2023" report has been added to  ResearchAndMarkets.com's offering. The Global Gene Editing Partnering Terms and Agreements 2010-2023 report provides an understanding and access to 400+...

at 20:01
Huma's platform is ready to use, reducing the time and cost for other companies to bring regulated SaMD products to market, democratising digital health innovation across the industryClass IIb certification expands the patient population and level of...

at 20:00
Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, today announces that two...

at 20:00
Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces the successful...



News published on 6 january 2023 at 12:15 and distributed by: